Antibody Drug Conjugates Contract Manufacturing Market Trends and Business Outlook 2028
Antibody Drug Conjugates Contract Manufacturing Industry Overview The global antibody drug conjugates contract manufacturing market size was valued at USD 7.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 12.3% from 2021 to 2028. The market is anticipated to witness significant growth over the forecast period on account of the increasing prevalence of cancer, rising demand for biologic therapy, and outsourcing of operations and services to contract manufacturing organizations. Many cancer medicines have toxicities that cause substantial side effects, limiting the dosage and efficacy of these medications and placing a significant burden on patients. An antibody drug conjugate can help to reduce some of these complications. Antibody Drug Conjugates (ADC) enable the delivery of particular medication dosage to a specific site of interest. They are most often used in oncology when a large medication dosage is required at the tumor site but not i...